Recent Progress in Amaryllidaceae Biotechnology

Plants belonging to the monocotyledonous Amaryllidaceae family include about 1100 species divided among 75 genera. They are well known as medicinal and ornamental plants, producing pharmaceutically important alkaloids, the most intensively investigated of which are galanthamine and lycorine. Amaryll...

Full description

Bibliographic Details
Main Authors: Vasil Georgiev, Ivan Ivanov, Atanas Pavlov
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/20/4670
_version_ 1797551126541762560
author Vasil Georgiev
Ivan Ivanov
Atanas Pavlov
author_facet Vasil Georgiev
Ivan Ivanov
Atanas Pavlov
author_sort Vasil Georgiev
collection DOAJ
description Plants belonging to the monocotyledonous Amaryllidaceae family include about 1100 species divided among 75 genera. They are well known as medicinal and ornamental plants, producing pharmaceutically important alkaloids, the most intensively investigated of which are galanthamine and lycorine. Amaryllidaceae alkaloids possess various biological activities, the most important one being their anti-acetylcholinesterase activity, used for the treatment of Alzheimer’s disease. Due to increased demand for Amaryllidaceae alkaloids (mainly galanthamine) and the limited availability of plant sources, in vitro culture technology has attracted the attention of researchers as a prospective alternative for their sustainable production. Plant in vitro systems have been extensively used for continuous, sustainable, and economically viable production of bioactive plant secondary metabolites. Over the past two decades, a significant success has been demonstrated in the development of in vitro systems synthesizing Amaryllidaceae alkaloids. The present review discusses the state of the art of in vitro Amaryllidaceae alkaloids production, summarizing recently documented plant in vitro systems producing them, as well as the authors’ point of view on the development of biotechnological production processes with a focus on the future prospects of in vitro culture technology for the commercial production of these valuable alkaloids.
first_indexed 2024-03-10T15:40:16Z
format Article
id doaj.art-3bb5e21bee2a46afa48e95bee00ce1a6
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T15:40:16Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-3bb5e21bee2a46afa48e95bee00ce1a62023-11-20T16:54:34ZengMDPI AGMolecules1420-30492020-10-012520467010.3390/molecules25204670Recent Progress in Amaryllidaceae BiotechnologyVasil Georgiev0Ivan Ivanov1Atanas Pavlov2Laboratory of Cell Biosystems, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Plovdiv 4000, BulgariaDepartment of Organic Chemistry and Inorganic Chemistry, University of Food Technologies, Plovdiv 4002, BulgariaLaboratory of Cell Biosystems, The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, Plovdiv 4000, BulgariaPlants belonging to the monocotyledonous Amaryllidaceae family include about 1100 species divided among 75 genera. They are well known as medicinal and ornamental plants, producing pharmaceutically important alkaloids, the most intensively investigated of which are galanthamine and lycorine. Amaryllidaceae alkaloids possess various biological activities, the most important one being their anti-acetylcholinesterase activity, used for the treatment of Alzheimer’s disease. Due to increased demand for Amaryllidaceae alkaloids (mainly galanthamine) and the limited availability of plant sources, in vitro culture technology has attracted the attention of researchers as a prospective alternative for their sustainable production. Plant in vitro systems have been extensively used for continuous, sustainable, and economically viable production of bioactive plant secondary metabolites. Over the past two decades, a significant success has been demonstrated in the development of in vitro systems synthesizing Amaryllidaceae alkaloids. The present review discusses the state of the art of in vitro Amaryllidaceae alkaloids production, summarizing recently documented plant in vitro systems producing them, as well as the authors’ point of view on the development of biotechnological production processes with a focus on the future prospects of in vitro culture technology for the commercial production of these valuable alkaloids.https://www.mdpi.com/1420-3049/25/20/4670alkaloidsAmaryllidaceaebioreactorsgalanthamineplant in vitro systems
spellingShingle Vasil Georgiev
Ivan Ivanov
Atanas Pavlov
Recent Progress in Amaryllidaceae Biotechnology
Molecules
alkaloids
Amaryllidaceae
bioreactors
galanthamine
plant in vitro systems
title Recent Progress in Amaryllidaceae Biotechnology
title_full Recent Progress in Amaryllidaceae Biotechnology
title_fullStr Recent Progress in Amaryllidaceae Biotechnology
title_full_unstemmed Recent Progress in Amaryllidaceae Biotechnology
title_short Recent Progress in Amaryllidaceae Biotechnology
title_sort recent progress in amaryllidaceae biotechnology
topic alkaloids
Amaryllidaceae
bioreactors
galanthamine
plant in vitro systems
url https://www.mdpi.com/1420-3049/25/20/4670
work_keys_str_mv AT vasilgeorgiev recentprogressinamaryllidaceaebiotechnology
AT ivanivanov recentprogressinamaryllidaceaebiotechnology
AT atanaspavlov recentprogressinamaryllidaceaebiotechnology